509 related articles for article (PubMed ID: 23448452)
1. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
2. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
3. [Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
Nill M; Müller MJ; Beck M; Stoeter P; Fellgiebel A
Fortschr Neurol Psychiatr; 2006 Dec; 74(12):687-95. PubMed ID: 17167727
[TBL] [Abstract][Full Text] [Related]
4. De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack.
Romani I; Borsini W; Nencini P; Morrone A; Ferri L; Frusconi S; Donadio VA; Liguori R; Donati MA; Falconi S; Pracucci G; Inzitari D
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2588-95. PubMed ID: 26298600
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.
Fellgiebel A; Gartenschläger M; Wildberger K; Scheurich A; Desnick RJ; Sims K
Cerebrovasc Dis; 2014; 38(6):448-56. PubMed ID: 25502511
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of different MRI and MR angiography measures in Fabry disease.
Fellgiebel A; Keller I; Marin D; Müller MJ; Schermuly I; Yakushev I; Albrecht J; Bellhäuser H; Kinateder M; Beck M; Stoeter P
Neurology; 2009 Jan; 72(1):63-8. PubMed ID: 19122032
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Fabry Disease in Young Patients with Stroke in Argentina.
Reisin RC; Mazziotti J; Cejas LL; Zinnerman A; Bonardo P; Pardal MF; Martínez A; Riccio P; Ameriso S; Bendersky E; Nofal P; Cairola P; Jure L; Sotelo A; Rozenfeld P; Ceci R; Casas-Parera I; Sánchez-Luceros A;
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):575-582. PubMed ID: 29132836
[TBL] [Abstract][Full Text] [Related]
8. Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.
Sarikaya H; Yilmaz M; Michael N; Miserez AR; Steinmann B; Baumgartner RW
Eur J Neurol; 2012 Nov; 19(11):1421-6. PubMed ID: 22680335
[TBL] [Abstract][Full Text] [Related]
9. Development and clinical consequences of white matter lesions in Fabry disease: a systematic review.
Körver S; Vergouwe M; Hollak CEM; van Schaik IN; Langeveld M
Mol Genet Metab; 2018 Nov; 125(3):205-216. PubMed ID: 30213639
[TBL] [Abstract][Full Text] [Related]
10. Value of the CHA
Liu D; Hu K; Schmidt M; Müntze J; Maniuc O; Gensler D; Oder D; Salinger T; Weidemann F; Ertl G; Frantz S; Wanner C; Nordbeck P
Clin Res Cardiol; 2018 Dec; 107(12):1111-1121. PubMed ID: 29797054
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.
Tuttolomondo A; Baglio I; Riolo R; Todaro F; Parrinello G; Miceli S; Simonetta I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203231
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry.
Romani I; Sarti C; Nencini P; Pracucci G; Zedde M; Cianci V; Nucera A; Moller J; Orsucci D; Toni D; Palumbo P; Casella C; Pinto V; Barbarini L; Bella R; Scoditti U; Ragno M; Mezzapesa DM; Tassi R; Volpi G; Diomedi M; Bigliardi G; Cavallini AM; Chiti A; Ricci S; Cecconi E; Linoli G; Sacco S; Rasura M; Giordano A; Bonetti B; Melis M; Cariddi LP; Dossi RC; Grisendi I; Aguglia U; Di Ruzza MR; Melis M; Sbardella E; Vista M; Valenti R; Musolino RF; Passarella B; Direnzo V; Pennisi G; Genovese A; Di Marzio F; Sgobio R; Acampa M; Nannucci S; Dagostino F; Dell'Acqua ML; Cuzzoni MG; Picchioni A; Calchetti B; Notturno F; Di Lisi F; Forlivesi S; Delodovici ML; Buechner SC; Biagini S; Accavone D; Manna R; Morrone A; Inzitari D
J Neurol Sci; 2024 Feb; 457():122905. PubMed ID: 38295534
[TBL] [Abstract][Full Text] [Related]
13. The pulvinar sign: frequency and clinical correlations in Fabry disease.
Burlina AP; Manara R; Caillaud C; Laissy JP; Severino M; Klein I; Burlina A; Lidove O
J Neurol; 2008 May; 255(5):738-44. PubMed ID: 18297328
[TBL] [Abstract][Full Text] [Related]
14. Neurological complications in Fabry disease.
Dütsch M; Hilz MJ
Rev Med Interne; 2010 Dec; 31 Suppl 2():S243-50. PubMed ID: 21211673
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.
Lanthier S; Saposnik G; Lebovic G; Pope K; Selchen D; Moore DF;
Stroke; 2017 Jul; 48(7):1766-1772. PubMed ID: 28596458
[TBL] [Abstract][Full Text] [Related]
16. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
Müller MJ; Müller KM; Dascalescu A; Whybra C; Baron K; Scheurich A; Mann K; Beck M; Schmidt LG; Fellgiebel A
Fortschr Neurol Psychiatr; 2005 Nov; 73(11):687-93. PubMed ID: 16283613
[TBL] [Abstract][Full Text] [Related]
17. Screening for health-related quality of life and its determinants in Fabry disease: A cross-sectional multicenter study.
Winter Y; Hilz M; Beuschlein F; Tsukimura T; Seifritz E; Lenders M; Brand E; Hennermann JB; Nowak A
Mol Genet Metab; 2023 Nov; 140(3):107692. PubMed ID: 37703724
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.
Rolfs A; Böttcher T; Zschiesche M; Morris P; Winchester B; Bauer P; Walter U; Mix E; Löhr M; Harzer K; Strauss U; Pahnke J; Grossmann A; Benecke R
Lancet; 2005 Nov; 366(9499):1794-6. PubMed ID: 16298216
[TBL] [Abstract][Full Text] [Related]
19. [Neurological manifestations of Fabry disease].
Mendióroz M; Fernández-Cadenas I; Montaner J
Rev Neurol; 2006 Dec 16-31; 43(12):739-45. PubMed ID: 17160925
[TBL] [Abstract][Full Text] [Related]
20. Posterior versus Anterior Circulation Stroke in Young Adults: A Comparative Study of Stroke Aetiologies and Risk Factors in Stroke among Young Fabry Patients (sifap1).
von Sarnowski B; Schminke U; Grittner U; Tanislav C; Böttcher T; Hennerici MG; Tatlisumak T; Putaala J; Kaps M; Fazekas F; Enzinger C; Rolfs A; Kessler C;
Cerebrovasc Dis; 2017; 43(3-4):152-160. PubMed ID: 28088807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
